1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NEK1 CTRPv2 pan-cancer AAC -0.16 3e-05
mRNA BEND6 CTRPv2 pan-cancer AAC -0.16 3e-05
mRNA SIRPB2 CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA ALG5 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA MEFV CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA EHD2 CTRPv2 pan-cancer AAC -0.16 3e-05
mRNA SCN8A CTRPv2 pan-cancer AAC -0.16 3e-05
mRNA MXI1 CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA SLC12A9 CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA SENP1 CTRPv2 pan-cancer AAC -0.15 4e-05
Download CSV